Sorry, we don't support IE.

We see that you are using Internet Explorer, an old and unsafe browser. Because of this we can not show you the website that we want you to see.

Please come back in a different browser like Chrome, Firefox or Microsoft Edge. We will be right here, see you in a minute!

machineMD Secures Topcon Healthcare, Inc. as Lead Investor to Advance Neurodiagnostics

Published on

Bern, Switzerland and La Jolla, CA, March 18, 2025  machineMD, an award-winning medical device company at the forefront of neurodiagnostic innovation, today announced a strategic investment from Topcon Healthcare, Inc., a global leader in robotic diagnostics and digital solutions. This partnership aligns with Topcon Healthcare’s mission to deliver Healthcare from the Eye™, enhancing access to high-quality care while optimizing healthcare costs.

Topcon Healthcare has joined machineMD’s pre-Series A funding round as the lead investor, underscoring a shared commitment to advancing neurodiagnostics through ocular data. This collaboration will integrate machineMD’s objective functional neurodiagnostics with Topcon’s Harmony® digital health information platform, fostering earlier detection of neurological diseases within a connected care ecosystem.

A Shared Vision for the Future of Diagnostics

Founded with a vision to enable faster, more accurate, and earlier diagnoses of neurological disorders, machineMD is pioneering oculometric analysis to assess brain function with precision. By leveraging neurodiagnostic expertise, the company is developing solutions that support individuals affected by conditions such as Multiple Sclerosis and Parkinson’s Disease.

“Topcon Healthcare and machineMD share a bold ambition to shape the future of neurodiagnostics—making it more accessible, scalable, and data-driven,” said Dominic Senn, CEO and Co-founder of machineMD. “With the backing of forward-thinking partners like Topcon Healthcare and our expanding network of clinical experts, we are accelerating our journey to establishing neurodiagnostics as the standard of care—ultimately improving millions of lives.”

Topcon Healthcare’s pioneering initiative, Healthcare from the Eye, utilizes ocular data to identify ocular, systemic, or neurological disease in a coordinated care system that includes eyecare providers, primary care providers, and specialty care providers using secure and responsible technology. Through this partnership, machineMD’s neurodiagnostic capabilities will be integrated into Topcon Healthcare’s multimodal retinal imaging technologies, unlocking faster, cost-effective pathways for neurological disease detection and management.

Unlocking Synergies and Scaling Impact

machineMD’s flagship product, neos®, leverages VR technology and gamified visual stimuli to capture precise oculomotor and pupillometric data. Already in clinical use across Switzerland and the USA, neos is streamlining workflows, paving the way for scalable and reimbursable neurodiagnostics.

Ali Tafreshi, CEO and President of Topcon Healthcare, Inc., stated: “Our investment in machineMD reflects our commitment to expanding ocular-based diagnostics into the realm of neurological diseases. machineMD’s expertise and cutting-edge technology will enable more precise and earlier diagnoses, ultimately improving patient outcomes.”

By combining machineMD’s neurodiagnostic functional biomarkers with Topcon Healthcare’s multimodal retinal imaging-based biomarkers, the partnership will enhance clinical decision-making and patient management. Delivering these innovations through the Harmony cloud-based platform will create a seamless digital ecosystem for ocular and neurological diagnostics, empowering healthcare professionals with integrated data-driven insights.

Together, Topcon Healthcare and machineMD are ushering in a new era of predictive, preventive, and personalized medicine for neurological and systemic diseases—driving earlier intervention, optimized healthcare utilization, and improved patient outcomes worldwide.
 


About Topcon Healthcare, Inc.

Topcon Healthcare, Inc. is part of Topcon Corporation (TSE 7732). We are a leading provider of digital healthcare solutions whose vision is to improve access and quality of healthcare while decreasing the cost of care. To achieve this vision, we created Healthcare from the Eye™, the strategy of applying AI models to imaging data from the eye to facilitate earlier detection and better management of disease. Healthcare from the Eye™ is powered by Harmony®, a cloud-based, vendor-inclusive digital health information platform enabling a connected care ecosystem.

A truly global business, Topcon Corporation is focused on developing solutions to solve societal challenges in the mega domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, physician shortages, and unequal access to healthcare. By investing in value-driven innovations, Topcon Corporation works to help people enjoy good health and a better quality of life.
 

About machineMD

machineMD is a medical device company, headquartered in Switzerland, with a subsidiary in Boston, USA, that is innovating at the intersection of neuroscience and ophthalmology. The company’s mission is to radically improve the measurement of brain function, with a vision for a world where people receive an accurate, fast, and early diagnosis of brain disorders www.machineMD.com
 

MEDIA CONTACTS

Topcon Healthcare
Leslie Amodei
VP, Marketing for Americas
[email protected]

machineMD
Luzia Campell
Senior Communications Specialist
[email protected]
www.machineMD.com

 

TRK-3 OMNIA

Recent posts

  • Svjetlost Eye Clinic Optimises Operations with Harmony from Topcon Healthcare

    Svjetlost Eye Clinic Optimises Operations with Harmony from Topcon Healthcare

    In today’s fast-evolving healthcare landscape, technology plays a pivotal role in enhancing patient care, improving efficiency, and streamlining workf...

    Learn more
  • machineMD Secures Topcon Healthcare, Inc. as Lead Investor to Advance Neurodiagnostics

    machineMD Secures Topcon Healthcare, Inc. as Lead Investor to Advance Neurodiagnostics

    Topcon Healthcare has joined machineMD’s pre-Series A funding round as the lead investor, underscoring a shared commitment to advancing neurodiagnosti...

    Learn more
  • Topcon Introduces TRK-3 OMNIA Auto Kerato-Refracto Tonometer to the European Market

    Topcon Introduces TRK-3 OMNIA Auto Kerato-Refracto Tonometer to the European Market

    Topcon Healthcare is pleased to announce the launch the TRK-3 OMNIA to the European market at the 42nd Congress of the ESCRS in Barcelona, Spain, Sept...

    Learn more